Ascentage Pharma Group International Balance Sheet

Balance Sheet Dec2022 Dec2023 Dec2024
Assets
Current Assets
Cash & Equivalents 200.42M142.21M122.35M
Cash & Current Investments 200.42M142.21M122.35M
Receivables - Net 20.64M11.39M
Receivables - Other 0.94M0.84M
Receivables 21.58M12.23M
Work In Process 0.72M0.37M
Finished Goods 1.57M0.53M
Inventory 2.29M0.90M
Prepaid Assets 12.49M16.88M
Current Assets 190.20M201.96M
Non-Current Assets
Property, Plant & Equipment (Net) 128.17M116.37M
Long-Term Investments 2.41M4.48M
Goodwill 3.49M3.38M
Intangibles 12.56M12.09M10.41M
Goodwill & Intangibles 12.56M15.59M13.79M
Long-Term Deferred Tax 934.60M8.47M6.98M
Other Non-Current Assets 2.47M3.47M8.12M
Non-Current Assets 163.61M156.68M
Liabilities
Current Liabilities
Accounts Payables 10.25M12.60M
Accumulated Expenses 0.58M2.03M
Other Accumulated Expenses 206.91M35.92M
Current Leases 1.38M1.29M
Current Deferred Revenue 5.44M5.13M
Total Current Liabilities 132.19M159.82M
Non-Current Liabilities
Non-Current Deffered Revenue 35.54M34.04M
Non-Current Deferred Tax Liability 2.60M2.26M1.66M
Operating Leases 2.57M3.11M4.14M
Other Non-Current Liabilities 2.59M0.87M
Total Non-Current Liabilities 211.63M161.25M
Total Liabilities 343.82M321.08M
Shareholder's Equity
Common Equity 60.86M9.99M37.56M
Shareholder's Equity 60.86M9.99M37.56M
Treasury Shares 3.02M0.00M
Retained Earnings -759.18M-790.56M